Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma
Phase III Multicentric IIL Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Treatment of Patients With Stage II-IV Follicular Lymphoma
Sponsor: Fondazione Italiana Linfomi - ETS
A PHASE3 clinical study on Follicular Lymphoma, this trial is ongoing. The trial is conducted by Fondazione Italiana Linfomi - ETS and has accumulated 8 data snapshots since 2005. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Unknown PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Unknown PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE3
Status: Unknown Status → Unknown
-
Jun 2023 — Jul 2024 [monthly]
Unknown Status PHASE3
-
Jan 2021 — Jun 2023 [monthly]
Unknown Status PHASE3
▶ Show 3 earlier versions
-
Sep 2020 — Jan 2021 [monthly]
Unknown Status PHASE3
-
Jun 2018 — Sep 2020 [monthly]
Unknown Status PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Unknown Status PHASE3
First recorded
Dec 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Fondazione Italiana Linfomi - ETS
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Acquaviva Delle Fonti (BA), Italy , Alessandria, Italy , Asti, Italy , Aviano, Italy , Bari, Italy , Biella, Italy , Bologna, Italy , Bolzano, Italy , Brescia, Italy , Brindisi, Italy and 52 more locations